Chen, Yong-Ping, Yu, Shi-Hui, Wei, Qian-Qian, Cao, Bei, Gu, Xiao-Jing, Chen, Xue-Ping, Song, Wei, Zhao, Bi, Wu, Ying, Sun, Ming-Ming, Liu, Fei-Fei, Hou, Yan-Bing, Ou, Ru-Wei, Zhang, Ling-Yu, Liu, Kun-Cheng, Lin, Jun-Yu, Xu, Xin-Ran, Li, Chun-Yu, Yang, Jing, Jiang, Zheng, Liu, Jiao, Cheng, Yang-Fan, Xiao, Yi, Chen, Ke, Feng, Fei, Cai, Ying-Ying, Li, Shi-Rong, Hu, Tao, Yuan, Xiao-Qin, Guo, Xiao-Yan, Liu, Hui, Han, Qing, Zhou, Qing-Qing, Shao, Na, Li, Jian-Peng, Pan, Ping-Lei, Ma, Sha, and Shang, Hui-Fang
BackgroundA large number of new causative and risk genes for amyotrophic lateral sclerosis (ALS) have been identified mostly in patients of European ancestry. In contrast, we know relatively little regarding the genetics of ALS in other ethnic populations. This study aims to provide a comprehensive analysis of the genetics of ALS in an unprecedented large cohort of Chinese mainland population and correlate with the clinical features of rare variants carriers.MethodsA total of 1587 patients, including 64 familial ALS (FALS) and 1523 sporadic ALS (SALS), and 1866 in-house controls were analysed by whole-exome sequencing and/or testing for G4C2 repeats in C9orf72. Forty-one ALS-associated genes were analysed.Findings155 patients, including 26 (40.6%) FALS and 129 (8.5%) SALS, carrying rare pathogenic/likely pathogenic (P/LP) variants of ALS causative genes were identified. SOD1was the most common mutated gene, followed by C9orf72, FUS, NEK1, TARDBPand TBK1. By burden analysis, rare variants in SOD1, FUSand TARDBPcontributed to the collective risk for ALS (p<2.5e-6) at the gene level, but at the allelic level TARDBPp.Gly294Val and FUSp.Arg521Cys and p.Arg521His were the most important single variants causing ALS. Clinically, P/LP variants in TARDBPand C9orf72were associated with poor prognosis, in FUSlinked with younger age of onset, and C9orf72repeats tended to affect cognition.ConclusionsOur data provide essential information for understanding the genetic and clinical features of ALS in China and for optimal design of genetic testing and evaluation of disease prognosis.